Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAR SYNERGY (OASIS 9)
NL-OMON56069Phase 4Completed
- Sponsor
- Population Health Research Institute
- Start
- Jul 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of colchicine and spironolactone in myocardial infarction (MI) (5 arms), sponsored by Population Health Research Institute. Started Jul 2020; status: completed.
02
Drugs
colchicinespironolactone
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NL-OMON56069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56069.